Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Monte Rosa Therapeutics
GLUE
$1.3B
| $953K | ﹤0.01% |
254,714
+132,614
| +109% | +$676K |
|
2352
Regal Rexnord
RRX
$14.1B
| $949K | ﹤0.01% |
+7,015
| New | +$1.09M |
|
|
KRON
2353
DELISTED
Kronos Bio
KRON
| $948K | ﹤0.01% |
764,126
-267,404
| -26% | -$272K |
|
2354
iShares Russell 2000 Growth ETF
IWO
$14.6B
| $945K | ﹤0.01% |
+3,600
| New | +$935K |
|
2355
Schwab US TIPS ETF
SCHP
$16.2B
| $943K | ﹤0.01% |
+36,280
| New | +$938K |
|
2356
Protalix BioTherapeutics
PLX
$187M
| $941K | ﹤0.01% |
804,600
-20,100
| -2% | -$23.7K |
|
|
PVBC
2357
DELISTED
Provident Bancorp
PVBC
| $941K | ﹤0.01% |
92,380
+2,600
| +3% | +$24K |
|
2358
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.6B
| $941K | ﹤0.01% |
4,100
+2,100
| +105% | +$482K |
|
2359
Fuel Tech
FTEK
$46.7M
| $936K | ﹤0.01% |
874,618
+44,512
| +5% | +$51.6K |
|
2360
Avantis International Small Cap Value ETF
AVDV
$19B
| $935K | ﹤0.01% |
14,400
+3,700
| +35% | +$244K |
|
|
ADVM
2361
DELISTED
Adverum Biotechnologies
ADVM
| $935K | ﹤0.01% |
136,257
+3,169
| +2% | +$29.5K |
|
|
GRAL
2362
GRAIL Inc
GRAL
$3.02B
| $935K | ﹤0.01% |
+60,804
| New | +$986K |
|
|
CLCO
2363
DELISTED
Cool Company
CLCO
| $935K | ﹤0.01% |
79,400
-15,400
| -16% | -$177K |
|
2364
Real Brokerage
REAX
$355M
| $932K | ﹤0.01% |
229,500
+46,400
| +25% | +$195K |
|
2365
Live Ventures
LIVE
$29.9M
| $930K | ﹤0.01% |
40,999
-2,600
| -6% | -$65.8K |
|
2366
Amplify Energy
AMPY
$166M
| $930K | ﹤0.01% |
137,200
-21,900
| -14% | -$144K |
|
2367
Lifetime Brands
LCUT
$195M
| $928K | ﹤0.01% |
108,051
+13,900
| +15% | +$139K |
|
2368
Legacy Housing
LEGH
$625M
| $922K | ﹤0.01% |
40,200
+24,800
| +161% | +$546K |
|
|
PRPH
2369
DELISTED
ProPhase Labs
PRPH
| $922K | ﹤0.01% |
22,051
-1,430
| -6% | -$74.9K |
|
2370
NI Holdings
NODK
$318M
| $918K | ﹤0.01% |
59,991
+1,300
| +2% | +$19.7K |
|
2371
Tredegar Corp
TG
$267M
| $918K | ﹤0.01% |
191,600
-5,000
| -3% | -$29.2K |
|
2372
Metropolitan Bank Holding Corp
MCB
$1.15B
| $918K | ﹤0.01% |
+21,800
| New | +$872K |
|
2373
WisdomTree US LargeCap Dividend Fund
DLN
$6.3B
| $917K | ﹤0.01% |
12,600
-24,400
| -66% | -$1.74M |
|
2374
NLI Holdings
NL
$289M
| $916K | ﹤0.01% |
151,914
-5,345
| -3% | -$39.9K |
|
2375
ClearPoint Neuro
CLPT
$461M
| $915K | ﹤0.01% |
169,700
+144,088
| +563% | +$834K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.